Silverback Thera

$3.47 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Silverback Thera

Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide.

Stock Analysis

last close $3.47
1-mo return 8.1%
3-mo return -23.6%
avg daily vol. 326T
52-week high 35.63
52-week low 2.8
market cap. $118M
forward pe -
annual div. -
roe -28.8%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 83.3%

Subscribe now for daily local and international financial news